Tacita Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62K Hold
131
0.04% 132
2025
Q4
$61.2K Sell
131
-11
-8% -$5.11K 0.04% 133
2025
Q3
$60.5K Hold
142
0.04% 131
2025
Q2
$54.4K Hold
142
0.04% 129
2025
Q1
$49.1K Hold
142
0.04% 130
2024
Q4
$42.6K Sell
142
-78
-35% -$27.3K 0.03% 135
2024
Q3
$89.4K Sell
220
-50
-19% -$18.3K 0.06% 108
2024
Q2
$86.7K Hold
270
0.06% 108
2024
Q1
$90.1K Hold
270
0.06% 111
2023
Q4
$73.1K Sell
270
-65
-19% -$16.1K 0.05% 116
2023
Q3
$82.4K Buy
335
+65
+24% +$17.8K 0.06% 111
2023
Q2
$82K Hold
270
0.06% 103
2023
Q1
$71K Hold
270
0.05% 110
2022
Q4
$65K Hold
270
0.05% 108
2022
Q3
$50K Hold
270
0.04% 113
2022
Q2
$45K Sell
270
-25
-8% -$5.37K 0.03% 140
2022
Q1
$74K Buy
295
+90
+44% +$22.6K 0.04% 116
2021
Q4
$53K Sell
205
-85
-29% -$20.8K 0.03% 140
2021
Q3
$70K Sell
290
-230
-44% -$56.2K 0.04% 112
2021
Q2
$108K Hold
520
0.07% 102
2021
Q1
$98K Sell
520
-38
-7% -$6.7K 0.06% 110
2020
Q4
$92K Buy
+558
New +$81.6K 0.06% 109

Other funds holding HCA

Tacita Capital's HCA Position: Q1 2026 in Review

Tacita Capital held its HCA Healthcare (HCA) position steady in Q1 2026 at 131 shares worth $62K. The position accounts for 0.04% of the portfolio, ranked #132.

Tacita Capital first reported a position in HCA in Q4 2020 and has held it in 22 quarters since. The position peaked at $108K in Q2 2021. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Tacita Capital held 131 shares of HCA Healthcare worth $62K as of Q1 2026.
  • Tacita Capital left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up 0.04% of Tacita Capital's portfolio in Q1 2026, its #132 holding.
  • Tacita Capital first reported a position in HCA Healthcare in Q4 2020 and has held it in 22 quarters since.
  • Tacita Capital's HCA Healthcare position peaked at $108K in Q2 2021.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Tacita Capital's 13F filing for Q1 2026, filed 7 May 2026.